Biomarkers offer great potential for improving management of cancer at every point from screening and detection, to diagnosis, staging, prognosis, and the assessment of treatment response.
Krystal Knapp
Advertisement
Articles by Krystal Knapp
As personalized medicine occupies a growing role in the pharmaceutical pipeline, major companies are changing their research and development paradigms.
The latest cancer study. A book-signing event. A hospital mural project. These topics and more are all fodder for the Fox Chase Cancer Center's Facebook page
Advertisement
Latest Updated Articles
Socializing Medicine: Oncology Joins Facebook EraMarch 24th 2011
Industry Testing New Models for Developing BiomarkersAugust 10th 2011
Advertisement
Advertisement
Trending on OncLive
1
Pumitamig Plus Chemo Demonstrates Encouraging Efficacy in Frontline NSCLC
2
Oral Administration Afforded by CDK2 Inhibitors May Ease the Price of Admission in Platinum-Resistant Ovarian Cancer
3
MAIC Shows Improved PFS With Zanubrutinib Over Ibrutinib in Treatment-Naive CLL
4
Iza-Bren Improves Survival in Unresectable, Locally Advanced or Metastatic TNBC
5